Vivus Inc (VVUS) Stock Price, Quote, News and Overview
NASDAQ:VVUS - Nasdaq -
VVUS Quote, Performance and Key Statistics
0.4665
-0.05 (-10.29%)
The current stock price of VVUS is 0.4665 null. In the past month the price decreased by -58.72%. In the past year, price decreased by -86.28%.
About VVUS
Company Profile
VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead investigational product in clinical development, Qnexa(TM), is expected to complete Phase 3 clinical trials for the treatment of obesity in 2009. Qnexa is also in Phase 2 clinical development for the treatment of type 2 diabetes. In the area of sexual health, VIVUS is in Phase 3 development with avanafil, its PDE5 inhibitor drug candidate, and in Phase 2 development of Luramist(TM), its drug candidate for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE(R) (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS.
Company Info
Vivus Inc
900 E. HAMILTON AVENUE SUITE 550
CAMPBELL CA 95008
CEO: John P. Amos
Phone: 650-934-5200
Vivus Inc / VVUS FAQ
What is the stock price of Vivus Inc today?
The current stock price of VVUS is 0.4665 null. The price decreased by -10.29% in the last trading session.
What is the ticker symbol for Vivus Inc stock?
The exchange symbol of Vivus Inc is VVUS and it is listed on the Nasdaq exchange.
On which exchange is VVUS stock listed?
VVUS stock is listed on the Nasdaq exchange.
What is Vivus Inc worth?
Vivus Inc (VVUS) has a market capitalization of 8.33M null. This makes VVUS a Nano Cap stock.
Should I buy Vivus Inc (VVUS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VVUS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VVUS, evaluating the profitability, health, valuation and growth aspects
- Vivus Inc (VVUS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Vivus Inc (VVUS) Sales and EPS estimates to see what analysts future expectations are.
- Vivus Inc (VVUS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Vivus Inc (VVUS) Insider and Institutional Ownership to learn about the owners and their transactions.
- Vivus Inc (VVUS) Stock Chart to make your own analysis
- Vivus Inc (VVUS) Latest news and press-releases to stay up to date.
Does Vivus Inc (VVUS) stock pay dividends?
VVUS does not pay a dividend.
What is the Price/Earnings (PE) ratio of Vivus Inc (VVUS)?
Vivus Inc (VVUS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.7).
VVUS Technical Analysis
VVUS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to VVUS. While VVUS is still in line with the averages on profitability rating, there are concerns on its financial health.
VVUS Financial Highlights
Over the last trailing twelve months VVUS reported a non-GAAP Earnings per Share(EPS) of -2.7. The EPS increased by 16.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -39.28% | ||
| ROA | -13.32% | ||
| ROE | N/A | ||
| Debt/Equity | -0.8 |
VVUS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 60% to VVUS. The Buy consensus is the average rating of analysts ratings from 1 analysts.